Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol Add-on to ASA or Clopidogrel in Healthy Volunteers
NCT02554721Phase 1Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Aug 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cilostazol in thrombosis (4 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Ex-vivo Inhibition Of Platelet Aggregation. Started Aug 2015; status: completed.
02
Drugs
cilostazol
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT02554721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02554721.